Release Testing at Portfolio Velocity
QC release testing is where portfolio scale hits finite lab capacity. Stability studies, release assays, and environmental monitoring multiply with every product — while analyst headcount stays flat. ZONTAL provides fleet-level operational visibility from Day 1 and governs every result through the release pipeline.
QC Capacity Is the Rate-Limiting Step
At portfolio scale, QC release testing compounds faster than any other operational function. Every new product multiplies assays, stability pulls, and environmental monitoring — while lab headcount and instrument uptime remain fixed.
Portfolio QC Multiplier
Every product in the portfolio requires release assays, stability testing, and environmental monitoring. At 30+ programs, QC capacity becomes the rate-limiting step — not R&D velocity or manufacturing throughput.
Manual Result Management
QC analysts manually review results, check acceptance criteria, verify reference standards, and document pass/fail decisions. Each batch release requires cross-checking 4–6 assay types across multiple analytical instruments.
Instrument Downtime Blindness
When analytical instruments fail during a release campaign, teams discover the problem after sample queues back up — not before. Without real-time device health monitoring, preventive maintenance is reactive, and release timelines slip.
Four Steps to Fleet Visibility
ZONTAL delivers operational visibility from the moment you go live. No months of configuration, no phased rollouts. Your QC team sees every device, every service, and every result flowing through the release pipeline.
Fleet Monitoring
Immediate visibility: Multi-site fleet monitoring, real-time device health, service-level orchestration — all visible in a single operational pane. Health meters, status indicators, and submission tracking from the moment you go live.
Device Health
Real-time device health status with failure root-cause classification. Script errors, configuration issues, and ingest failures surfaced and categorized — before they cascade into release delays.
Release Assays
QC Control tab monitoring 4 release assay methods (SEC, PS-20, CBA Potency, Protein Concentration) with acceptance criteria, reference standards (NISTmAb RM 8671, MK-6070 Ref Lot), and %CV tracking.
System Suitability
Method suitability trending, reference standard performance monitoring, and out-of-specification event tracking. Continuous verification that analytical methods are performing within specifications.
Two Principles Compounding for QC Release
QC Release Throughput compounds from two principles working together. Governed data ingestion feeds fleet-level monitoring, and scientific context governs every release result through the pipeline.
AI-driven OOS investigation and release prediction require governed,
contextualized QC data — not raw instrument output.
Evaluate
readiness with the five-question framework →
Integration Industrialization
Data Hub connects 150+ vendors and 400+ instrument models through governed Integration Factories. Every data point is validated and traced from source instrument to scientific context with full provenance. Governed connectors to every QC instrument — HPLC, plate readers, particle counters, UV spectrometers — enable fleet-level monitoring from Day 1.
- 150+ vendor instruments supported
- 400+ instrument models connected
- 8 core techniques · 80+ variants
- Fleet-wide device monitoring with real-time health status
Scientific Context & Lineage
Digital Lab and Platform Modules build the scientific context graph — ontology mapping, cross-system identity reconciliation, and full lineage from instrument through result to insight. Every release result is traced: batch to sample to method to instrument to raw data. QC Control monitoring enforces acceptance criteria with drift alerting.
- Ontology mapping across all data domains
- Cross-system identity reconciliation
- Full lineage graph: instrument → method → sample → result
- Batch → sample → method → instrument traceability with spec enforcement
Why QC Release Speed Matters
Quality failures dominate both FDA rejections and drug shortages. Faster, governed QC release directly reduces these risks.
40% of Shortages Are Demand-Driven
Quality problems remain one of the most common reasons for drug shortages, with 40% demand-driven. QC release throughput is the last line of defense before supply disruptions cascade.
US FDA, FY2023 Drug Shortages Report323 Active Shortages
Drug shortages peaked at 323 active shortages in Q1 2024. Quality-driven supply disruptions compound when QC release is slow or error-prone.
ASHP, Drug Shortage Statistics, 202550% Better Risk-Sensing
Biopharma supply chain digitization delivers 50% better risk-sensing and 50% enhanced yields. Governed QC release is the last mile of that digital chain.
Dr. Laks Pernenkil, Deloitte, January 2024How This Outcome Applies Across Scientific Domains
PAT-Driven Real-Time Release Testing
Real-Time Release Testing (RTRT) uses in-process measurements to evaluate and ensure quality during manufacturing — replacing post-production QC testing bottlenecks. synTQ provides the process control capability: multivariate quality predictions from Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) monitored in real time, feeding directly into the governed data infrastructure that powers batch release decisions.
- Real-time CPP/CQA monitoring feeding batch release workflows
- Multivariate statistical process control (MSPC) for quality prediction
- In-process NIR, Raman, and UV measurements orchestrated by synTQ
- GxP-compliant PAT knowledge management with 21 CFR Part 11 audit trails
GMP Workflows Orchestrated End-to-End
Manufacturing QC workflows — batch release, environmental monitoring, in-process controls — orchestrated through the same data infrastructure that supports R&D. The governed Integrate and Contextualize ensure every QC result carries full traceability from raw instrument data to Certificate of Analysis (CoA).
- Batch release workflows with automated data aggregation
- Environmental monitoring integration across clean rooms
- In-process control (IPC) data linked to batch records
- Out-of-Specification (OOS) investigation workflows with full audit trail
Validated by Industry Leaders
Published content from pharmaceutical companies solving real scientific data challenges.
Trusted by 6 of the 10 largest pharmaceutical companies in the world
And leading biotechs and agrochemical companies
Build the Foundation for QC Release Throughput
Experience the operational dashboard — fleet monitoring, device health, release assay tracking, and system suitability trending with your own QC data.